Anxo Pharmaceutical Co (ROCO:6677) Interest Expense : NT$-17.5 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Anxo Pharmaceutical Co's interest expense for the six months ended in Jun. 2023 was NT$ -9.2 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-17.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Anxo Pharmaceutical Co's Operating Income for the six months ended in Jun. 2023 was NT$ 19.8 Mil. Anxo Pharmaceutical Co's Interest Expense for the six months ended in Jun. 2023 was NT$ -9.2 Mil. Anxo Pharmaceutical Co's Interest Coverage for the quarter that ended in Jun. 2023 was 2.16. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anxo Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Anxo Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co Interest Expense Chart

Anxo Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-15.77

-16.81

-14.19

-12.76

-15.19

Anxo Pharmaceutical Co Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial												-6.44	-6.33	-6.82	-8.37	-9.17

Anxo Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-17.5 Mil.

Anxo Pharmaceutical Co (ROCO:6677) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anxo Pharmaceutical Co's Interest Expense for the six months ended in Jun. 2023 was NT$-9.2 Mil. Its Operating Income for the six months ended in Jun. 2023 was NT$19.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was NT$528.1 Mil.

Anxo Pharmaceutical Co's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2023 )	/	Interest Expense (Q: Jun. 2023 )
	=	-1	*	19.791	/	-9.167
	=	2.16

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Anxo Pharmaceutical Co Ltd interest coverage is 3.83, which is low.

Anxo Pharmaceutical Co (ROCO:6677) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN

Website

http://www.anxo.com.tw

Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines